Skip to main content
Cardiology Research and Practice logoLink to Cardiology Research and Practice
. 2020 Feb 14;2020:1481937. doi: 10.1155/2020/1481937

Reconstruction of a lncRNA-Associated ceRNA Network in Endothelial Cells under Circumferential Stress

Zhuhui Huang 1, William Adiwignya Winata 1, Kui Zhang 1, Yang Zhao 1, Yang Li 1, Ning Zhou 1, Shaoyou Zhou 1, Wei Fu 1, Bokang Qiao 2, Guoqi Li 2, Yihui Shao 2, Jubing Zheng 1,, Ran Dong 1,
PMCID: PMC7042510  PMID: 32148949

Abstract

Background

Numerous studies have highlighted that long noncoding RNA (lncRNA) can indirectly regulate the expression of mRNAs by binding to microRNA (miRNA). LncRNA-associated ceRNA networks play a vital role in the initiation and progression of several pathological mechanisms. However, the lncRNA-miRNA-mRNA ceRNA network in endothelial cells under cyclic stretch is seldom studied.

Methods

The miRNA, mRNA, and lncRNA expression profiles of 6 human umbilical vein endothelial cells (HUVECs) under circumferential stress were obtained by next-generation sequencing (NGS). We identified the differential expression of miRNAs, mRNAs, and lncRNAs using the R software package GDCRNATools. Cytoscape was adopted to construct a lncRNA-miRNA-mRNA ceRNA network. In addition, through GO and KEGG pathway annotations, we analyzed gene functions and their related pathways. We also adopted ELISA and TUNEL to investigate the effect of si-NEAT1 on endothelial inflammation and apoptosis.

Results

We recognized a total of 32978 lncRNAs, 1046 miRNAs, and 31958 mRNAs in 6 samples; among them, 155 different expressed lncRNAs, 74 different expressed miRNAs, and 960 different mRNAs were adopted. Based on the established theory, the ceRNA network was composed of 13 lncRNAs, 44 miRNAs, and 115 mRNAs. We constructed and visualized a lncRNA-miRNA-mRNA network, and the top 20 nodes are identified after calculating their degrees. The nodes with most degrees in three kinds of RNAs are hsa-miR-4739, NEAT1, and MAP3K2. Functional analysis showed that different biological processes enriched in biological regulation, response to stimulus and cell communication. Pathway analysis was mainly enriched in longevity regulating, cell cycle, mTOR, and FoxO signaling pathway. Circumferential stress can significantly downregulate NEAT1, and after transducing si-NEAT1 for 24 h, inflammatory cytokine IL-6 and MCP-1 were significantly increased; furthermore, fewer TUNEL-positive cells were found in the si-NEAT1 treated group.

Conclusions

The establishing of a ceRNA network can help further understand the mechanism of vein graft failure. Our data demonstrated that NEAT1 may be a core factor among the mechanical stress factors and that cyclic stress can significantly reduce expression of NEAT1, give rise to inflammation in the early stage of endothelial dysfunction, and promote EC apoptosis, which may play an essential role in vein graft failure.

1. Introduction

Coronary Artery Bypass Grafting (CABG) is an economical and effective treatment for most cases of multiple or left main coronary arteries [1]. During the surgery, the patient's autogenous vein is one of the most commonly used conduits for bypass grafting. However, given that vascular smooth muscle cell (VSMC) could give rise to abnormal neointimal hyperplasia of the veins, as many as 50% of CABG operations end up in failure [2]. Jeremy et al. reported that the reasons for vein graft failure involve physical, chemical, and biological factors, including the adhesion of platelets and white blood cells, the change of hemodynamics, activated matrix metalloproteinases and excessive release of platelet-derived growth factor-BB and thrombin, and the superposition effect of atherosclerosis [36]. After the vein was transplanted from the venous system to the arterial system, the inflammation and apoptosis of ECs could be induced by changing the mechanical environment, which plays an important role in several pathological processes, including intimal hyperplasia, atherosclerosis, and occlusion [7]. So far, no ideal method has been found to prevent and deal with such adverse events. Wadey et al. observed the different responses between arterial and vein endothelial cells to blood flow and attributed to the different responses to the epigenetic memory of vastly different hemodynamic environments [8].

A plethora of evidence has shown that miRNAs are involved in the pathogenesis of vein graft failure. Previous studies have shown that the expression of miR-21 was significantly increased in various vascular injury models, and the downregulated miR-21 expression serves to improve the intimal thickening of arterial vessels after grafting [9, 10]. MiR-145 exhibits an inhibitory effect on the proliferation, migration, and phenotype transformation of smooth muscle [11]. Ohnaka et al. conducted a nonvirus transfection of miR-145 and observed that the transplanted vein neointimal thickening was suppressed in rabbits [12]. Jan Fiedler et al. observed that higher expression of miR-24 in the myocardial infarction (MI) model promoted endothelial cell apoptosis and that suppressed miR-24 expression using local transfection adenovirus promoted the formation of new veins, thereby improving blood perfusion [13]. MiR-92a was reported to play the part of inhibiting the proliferation and migration of EC cells; the downregulated miR-92a expression using the antagomir method led to improved vascular endothelialization after balloon injury and reduced intimal thickening [14].

LncRNAs could competitively combine with the miRNA response element (MRE) to repress miRNA's regulation of target mRNAs. Such a lncRNA-miRNA-mRNA competing endogenous RNA (ceRNA) network has been demonstrated in several diseases, yet its application in vein graft failure is to be clarified. Therefore, it is essential to detect the ceRNA coregulatory of ECs suffering from cyclic stress by conducting bioinformatic analysis, which is of great help to construct the systematic regulatory network and to explore the correlation between the main biomarkers.

2. Materials and Methods

2.1. Cyclic Stretch Stimulation

Human umbilical vein endothelial cells (HUVECs, ScienCell Research Laboratories, San Diego, CA, USA) were maintained in endothelial cell medium (ECM, ScienCell Research Laboratories, San Diego, CA, USA) with 10% fetal bovine serum (FBS, ThermoFisher Scientific, Waltham, MA, USA) at 37°C with 5% CO2. The ECs were then plated on the collagen-coated plates (Flexcell International Corporation, McKeesport, PA, USA). We adopted a computer-controlled circumferential stress unit (Flexcell 5100, Flexcell International Corporation, McKeesport, PA) to compose cyclic stretch to HUVEC for 24 hours including a condition of cyclic deformation at 60 cycles/min and elongation at 18%. The control group was maintained in the 6-well plate under the same condition but without mechanical stretch.

2.2. RNA Isolation

The HUVECs in two groups were harvested after 24 hours. Total RNA was obtained from ECs using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instruction. In brief, cells were lysed in the Eppendorf tubes using TRIZOL reagent, and then RNA was separated and precipitated, finally, the total RNA will be dissolved in DEPC-treated water for further experiments. The RNA concentration and purity were checked using NanoDrop 2000 (ThermoFisher Scientific, Waltham, MA, USA) with criteria of OD A260/A280 (>1.8) and A260/A230 (>1.6), Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) was adopted to access the yield and quality by RIN >7.0, and gDNA contamination was evaluated by gel electrophoresis.

2.3. RNA Library Preparation and Sequencing

Ribo-Zero Magnetic Gold Kit (Illumina, San Diego, CA, USA) and NEBNext RNA Library Prep Kit (New England Biolabs, Ipswich, MA, USA) were adopted to prepare the whole transcriptome libraries. Quality control and quantification was done by using the BioAnalyzer 2100 system (Kapa Biosystems, Woburn, MA, USA). The resulting libraries were sequenced on a HiSeq2000 instrument (Illumina, San Diego, CA, USA), and we used approximately 1 μg total RNA to prepare an RNA library according to the protocol. Then, we performed the single-end sequencing (50 bp) on Hiseq2500 (Illumina, San Diego, CA, USA) following the vendor's recommended protocol. We used FastQC software to check for potential sequencing issues and contaminants in the raw sequencing reads. Reads with quality scores below 30, adapter sequences, and primers were trimmed. Reads with a length of <60 bp were discarded sequently. We used TopHat 2.0 to align sequence reads to the human genome (GRCh38), and the results were reconstructed with Cufflinks. All transcriptomes were pooled and merged to generate a final transcriptome using Cuffmerge. After the final transcriptome was produced, Cuffdiff was used to estimate the abundance of all transcripts based on the final transcriptome. For mRNA and lncRNA analyses, the RefSeq and Ensembl transcript databases were chosen as the annotation references. We used the Coding Potential Calculator (CPC) [15] to predict transcripts with coding potential. The transcripts that remained were considered reliably expressed lncRNAs. As for miRNAs, reads with a length <10 nt and >34 nt were discarded. The clean reads were aligned against the miRNA precursor of Homo sapiens and other species in miRBase 22.1 [16] to identify known miRNAs. The unannotated sequences were mapped to the human genome to analyze their expression and distribution in the genome and then used to predict potential novel miRNA candidates by the Mireap program.

2.4. Construction of lncRNA-miRNA-mRNA ceRNA Network

The clean reads of 6 EC samples were imported and analyzed by R 3.6 software after transformation. We adopted a R package of GDCRNATools to analyze the sequencing data. It is a novel R package for integrative analysis of RNA-seq data, and it allows users to conduct ceRNA networks and other routine analyses based on online databases [17]. In short, lncRNA, miRNA, and mRNA expression profiles of fold change (FC) ≥1.5 and P value ≤0.05 were retained. To construct the ceRNA network, we predicted miRNA-mRNA and lncRNA-miRNA interactions based on starbase V3.0 [18], miRcode [19], and miRTarBase [20] based on our sequencing data; then, according to ceRNA hypothesis, the miRNAs negatively regulated by lncRNAs and its downregulated target mRNAs were selected, and the common miRNAs interacting with both lncRNAs and mRNAs were seen as an inclusion criteria. After that, the lncRNA-associated ceRNA network was reconstructed and visualized using Cytoscape software V3.5 (San Diego, CA, USA) based on the R output. We used different colors and shapes to represent the three types of RNA, respectively, and all node degrees were calculated simultaneously using the software plugin CytoHubba.

2.5. Functional Enrichment Analysis

To understand the potential regulative role of the lncRNA-miRNA-mRNA network, we used the Database for Annotation, Visualization, and Integrated Discovery (DAVID) bioinformatics resources [21] and WEB-based gene set analysis toolkit (Webgestalt) [22]; to enrich the downstream mRNA to molecular functions and pathways, we enriched KEGG pathways using Wedgestalt, and each pathway was listed and ranked by their enrichment ratio. Furthermore, GO analysis was carried out using the DAVID database, molecular functions, and biological processes, and cellular component of the differentially expressed genes were elucidated.

2.6. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) Validation

To validate the hub gene that we identified in the bioinformatics analysis, qRT-PCR was performed using the riboSCRIPT mRNA/lncRNA qRT-PCR starter kit (RIBO bio, Guangzhou, China) under instructions. Briefly, total RNA was isolated using TRIzol as previously described, then RNA was reverse transcripted to cDNA using random primer and Oligo (dT), and then qPCR was performed using the three-step method. Relative quantification of lncRNA was calculated using the 2-ΔΔCt method and was normalized to GAPDH as a reference. The template sequence for qRT-PCR is NEAT1 5′-GGCAGGTCTAGTTTGGGCAT-3′; 5′-CCTCATCCCTCCCAGTACCA-3′; GAPDH 5′-CATGGCCTTCCGTGTTCCTA-3′; 5′-CGCCTCCTTTTCCTCTCAT-3′.

2.7. Enzyme-Linked Immunosorbent Assay (ELISA)

The levels of inflammatory cytokines secreted by endothelial cells transduced with si-NEAT1 (RIBO bio, Guangzhou, China) and control reagents were measured by ELISA. We transduced the si-NEAT1 into endothelial cells after 3-4 passages using Lipofectamine 3000 Reagent (ThermoFisher Scientific, Waltham, MA, USA) according to the established protocol. After that, ELISA was performed on a 96-well plate using ELISA kits (BD Biosciences, San Diego, CA) according to the manufacturer's protocol. We used a spectrophotometer to measure the absorbance at a wavelength of 450 nm. Several common Inflammatory cytokines including IL-6, MCP-1, and ICAM-1 were measured to confirm the effect of downregulating NEAT1 on endothelial inflammatory.

2.8. TUNEL and DAPI Staining

To determine the effect on apoptosis after downregulating NEAT1, we performed TUNEL assay on the endothelial cells described above using the In Situ Cell Death Detection kit (Roche, Mannheim, Germany) according to the product's instructions. The cell slide was fixed in 4% paraformaldehyde at room temperature for 20 mins and washed using PBS for 3 times. After that, we used 1% Triton X-100 to increase cell permeability. The fixed cells were incubated with terminal deoxynucleotide transferase recombinant (rTdT)-catalyzed reaction mixture for 30 min at room temperature. Then, we used Streptavidin-FITC to label the apoptosis cells and DAPI to illustrate the nuclei. Apoptotic cells were photographed under a fluorescence microscope at an excitation wavelength of 450 nm and emission wavelength of 515 nm.

2.9. Statistical Analysis

We used SPSS version 23.0 and R version 3.6 to analyze the sequencing data, Student's t-tests were adopted to compare the difference between two groups, and repeated measures were tested by one-way analysis. P < 0.05 was the threshold to be statistically significant. In addition, we use fold changes and Student's t-tests to identify specific RNAs in the sequencing results. The ncRNAs and mRNAs with FC ≥ 1.5 and P < 0.05 were considered as differentially expressed.

3. Results

3.1. Altered lncRNA, miRNA, and mRNA Expression in the Endothelial Cells

The expression of lncRNAs, miRNAs, and mRNAs in the endothelial cells under cyclic stretch for 24 hours was profiled using RNA sequencing. After processing the raw data, we identified a total of 32978 lncRNAs, 1046 miRNAs, and 31958 mRNAs in 6 samples of endothelial cells compared with the established databases. We adopted FC ≥ 1.5 and P value ≤0.05 as selective criteria; after screening, we got 155 different expressed lncRNAs, 74 different expressed miRNAs, and 960 different mRNAs, among them, 39 lncRNAs, 35 miRNAs, and 568 mRNAs were upregulated, while 116 lncRNAs, 39 miRNAs, and 392 mRNAs were downregulated. The most upregulated were AL031282.2, hsa-miR-151a-5p, and SSUH2; by contrast, the most downregulated were AC092162.2, hsa-miR-100-5p, and RAD21L1. Expression profiles are depicted as heatmap (Figure 1) and dot plot (Figure 2) after normalization; additionally, the top 20 upregulated and downregulated members of each kind of RNAs are listed in Tables 13. These results suggest that circumferential stress may vary transcriptional regulation in human endothelial cells.

Figure 1.

Figure 1

RNA profiling in HUVECs with and without mechanical stretch stimulation. Red boxes represent upregulated genes and blue boxes represent downregulated genes. Each group has 3 replicates.

Figure 2.

Figure 2

Volcano plot of the differently expressed RNAs. Upregulated genes are marked in light red; downregulated genes are marked in light green. FC ≥ 1.5 and P value ≤0.05 were chosen as selective criteria, 155 different expressed lncRNAs, 74 different expressed miRNAs, and 960 different mRNAs were identified.

Table 1.

Top 40 differently expressed lncRNAs in sequencing analysis.

Gene ID Gene symbol P FC FDR Regulation
ENSG00000268575 AL031282.2 0.00062 5.79268 0.01580 Up
ENSG00000237813 AC002066.1 0.00341 3.65619 0.04825 Up
ENSG00000234378 AC098828.3 0.00016 2.08850 0.00658 Up
ENSG00000247095 MIR210HG 8.07E – 05 1.79213 0.00410 Up
ENSG00000231412 AC005392.2 5.17E – 05 1.60687 0.00297 Up
ENSG00000275216 AL161431.1 3.17E – 09 1.36434 1.98E – 06 Up
ENSG00000268621 IGFL2-AS1 0.00059 1.13821 0.01523 Up
ENSG00000261040 WFDC21P 0.00145 1.96944 0.02708 Up
ENSG00000235852 AC005540.1 7.91E – 10 1.89379 9.91E – 07 Up
ENSG00000225855 RUSC1-AS1 5.50E – 05 1.88656 0.00308 Up
ENSG00000258667 HIF1A-AS2 0.00081 1.84409 0.01852 Up
ENSG00000261780 AC105243.1 1.99E – 08 1.83428 8.21E – 06 Up
ENSG00000241316 SUCLG2-AS1 1.58E – 07 1.79216 3.62E – 05 Up
ENSG00000269926 DDIT4-AS1 3.87E – 08 1.76033 1.31E – 05 Up
ENSG00000228437 LINC02474 1.87E – 05 1.71344 0.00141 Up
ENSG00000231721 LINC-PINT 3.13E – 07 1.69794 6.14E – 05 Up
ENSG00000223901 AP001469.1 0.00123 1.69227 0.02438 Up
ENSG00000167046 AL357033.1 2.17E – 07 1.67088 4.62E – 05 Up
ENSG00000214049 UCA1 0.00172 1.66915 0.03007 Up
ENSG00000235904 RBMS3-AS3 1.30E – 07 1.64632 3.35E – 05 Up
ENSG00000230552 AC092162.2 2.81E – 05 –5.64846 0.00191 Down
ENSG00000248802 AC078850.2 0.00027 –4.84467 0.00909 Down
ENSG00000234871 LINC01032 0.00285 –3.87282 0.04276 Down
ENSG00000272482 AC254633.1 8.34E – 07 –3.69988 0.00012 Down
ENSG00000259437 AC093334.1 0.00308 –3.48527 0.04517 Down
ENSG00000227848 SUCLA2-AS1 0.00314 –3.37469 0.04590 Down
ENSG00000258561 AL359232.1 0.00047 –2.50748 0.01311 Down
ENSG00000225339 AL354740.1 7.71E – 07 –2.31612 0.00012 Down
ENSG00000233818 AP000695.2 0.00022 –2.17093 0.00797 Down
ENSG00000255864 AC069208.1 6.51E – 06 –1.71555 0.00064 Down
ENSG00000258969 LINC02307 0.00028 –1.64003 0.00936 Down
ENSG00000257114 LINC02450 0.00036 –1.54184 0.01101 Down
ENSG00000227925 LINC01655 3.40E – 07 –1.46588 6.51E – 05 Down
ENSG00000275119 AC244131.2 0.00281 –1.38628 0.04225 Down
ENSG00000259635 AC100830.1 0.00085 –1.33988 0.01888 Down
ENSG00000225791 TRAM2-AS1 0.00091 –1.27027 0.01999 Down
ENSG00000238042 LINC02257 7.40E – 10 –1.26935 9.91E – 07 Down
ENSG00000261094 AC007066.2 0.00312 –1.23834 0.04567 Down
ENSG00000257176 AC009318.1 0.00047 –1.18344 0.01311 Down
ENSG00000226370 LINC00375 0.00076 –1.17222 0.01790 Down

Table 2.

Top 40 differently expressed miRNAs in sequencing analysis.

Gene symbol P FC Average expression Regulation
hsa-miR-151a-5p 0.00830 4.967587 11.843500 Up
hsa-miR-92a-3p 0.00552 4.717289 13.551630 Up
hsa-miR-148b-3p 0.0498 4.493670 12.211111 Up
hsa-miR-21-5p 0.00539 4.433062 16.684564 Up
hsa-let-7i-5p 0.00758 4.169530 11.920628 Up
hsa-miR-30a-5p 0.00624 4.151897 12.066384 Up
hsa-miR-10a-5p 0.00737 3.555440 14.343647 Up
hsa-miR-99b-5p 0.01085 3.496305 14.620504 Up
hsa-let-7f-5p 0.00700 2.995222 11.353220 Up
hsa-miR-222-3p 0.01295 2.850281 10.920330 Up
hsa-miR-4284 0.00777 2.654383 0.863570 Up
hsa-miR-374a-5p 0.01244 2.405461 5.723251 Up
hsa-miR-27b-3p 0.00747 2.125160 11.039688 Up
hsa-miR-18a-5p 0.00708 1.873955 3.569991 Up
hsa-miR-96-5p 0.01107 1.783202 7.315302 Up
hsa-miR-651-5p 0.0435 1.776173 2.523913 Up
hsa-miR-20a-5p 0.01147 1.774804 7.238996 Up
hsa-miR-4521 0.0355 1.773481 7.092690 Up
hsa-miR-210-5p 0.00520 1.502487 2.287306 Up
hsa-miR-10a-3p 0.01273 1.431455 7.732293 Up
hsa-miR-100-5p 0.00749 –4.78274 17.89078 Down
hsa-miR-223-3p 0.00605 –4.61353 0.45163 Down
hsa-miR-144-3p 0.03854 –4.05538 0.32115 Down
hsa-miR-142-5p 0.04626 –3.43605 0.83274 Down
hsa-miR-4772-5p 0.00895 –3.15733 0.86166 Down
hsa-let-7a-5p 0.00921 –2.71715 13.60388 Down
hsa-miR-199a-5p 0.03156 –2.67627 1.37259 Down
hsa-miR-451a 0.04254 –2.37644 2.03836 Down
hsa-miR-3617-5p 0.01273 –2.00633 0.13456 Down
hsa-miR-4443 0.00648 –1.68771 0.85807 Down
hsa-miR-23a-5p 0.00518 –1.54230 1.53357 Down
hsa-miR-3940-3p 0.00762 –1.47825 1.12245 Down
hsa-miR-143-3p 0.00738 –1.47642 4.87572 Down
hsa-miR-191-3p 0.00607 –1.44144 1.31566 Down
hsa-miR-148a-5p 0.00701 –1.33610 1.32972 Down
hsa-miR-7976 0.00962 –1.29245 4.13996 Down
hsa-miR-185-3p 0.01159 –1.27379 1.12633 Down
hsa-miR-27b-5p 0.00107 –1.26108 3.56518 Down
hsa-miR-105-5p 0.01158 –1.25366 1.08368 Down
hsa-miR-576-3p 0.00686 –1.16215 4.20788 Down

Table 3.

Top 40 differently expressed mRNAs in sequencing analysis.

Gene ID Gene symbol P FC FDR Regulation
ENSG00000125046 SSUH2 0.00164 4.34497 0.02918 Up
ENSG00000187134 AKR1C1 0.00012 2.44192 0.00543 Up
ENSG00000135373 EHF 0.00016 2.31835 0.00644 Up
ENSG00000231924 PSG1 0.00105 2.31706 0.02229 Up
ENSG00000145358 DDIT4L 0.00070 2.10851 0.01696 Up
ENSG00000182957 SPATA13 0.00221 2.04019 0.03561 Up
ENSG00000147872 PLIN2 1.22E – 07 1.67389 3.22E – 05 Up
ENSG00000004799 PDK4 1.35E – 07 1.63004 3.35E – 05 Up
ENSG00000173237 C11orf86 0.00016 1.62141 0.00633 Up
ENSG00000100292 HMOX1 1.34E – 06 1.60182 0.00017 Up
ENSG00000178150 ZNF114 2.22E – 05 1.55896 0.00162 Up
ENSG00000109846 CRYAB 3.12E – 07 1.54027 6.14E – 05 Up
ENSG00000114268 PFKFB4 3.11E – 07 1.50759 6.14E – 05 Up
ENSG00000087086 FTL 9.60E – 10 1.46587 1.04E – 06 Up
ENSG00000120738 EGR1 1.11E – 07 1.35264 3.07E – 05 Up
ENSG00000167996 FTH1 8.01E – 13 1.33776 6.52E – 09 Up
ENSG00000163347 CLDN1 6.03E – 09 1.31604 3.27E – 06 Up
ENSG00000132196 HSD17B7 0.00027 1.24930 0.00902 Up
ENSG00000128510 CPA4 8.09E – 05 1.23659 0.00410 Up
ENSG00000104419 NDRG1 1.08E – 09 1.20327 1.10E – 06 Up
ENSG00000244588 RAD21L1 5.43E – 05 –6.29595 0.00305 Down
ENSG00000268434 AC011530.1 0.00276 –4.12341 0.04191 Down
ENSG00000198049 AVPR1B 0.00341 –3.74115 0.04818 Down
ENSG00000269955 C7orf55 0.00108 –3.40469 0.02263 Down
ENSG00000140807 NKD1 0.00221 –3.15605 0.03561 Down
ENSG00000112139 MDGA1 0.00029 –2.51469 0.00953 Down
ENSG00000118557 PMFBP1 0.00058 –2.43974 0.01516 Down
ENSG00000162496 DHRS3 4.02E – 14 –2.41244 0.00000 Down
ENSG00000141469 SLC14A1 0.00097 –2.10327 0.02102 Down
ENSG00000102174 PHEX 0.00054 –2.06964 0.01443 Down
ENSG00000214279 SCART1 0.00039 –1.83248 0.01167 Down
ENSG00000065320 NTN1 0.00145 –1.81924 0.02707 Down
ENSG00000260851 AC010542.3 0.00214 –1.80247 0.03497 Down
ENSG00000273167 AL359736.1 0.00024 –1.78956 0.00822 Down
ENSG00000175093 SPSB4 0.00012 –1.78920 0.00528 Down
ENSG00000054219 LY75 0.00072 –1.68978 0.01736 Down
ENSG00000171189 GRIK1 0.00063 –1.66405 0.01580 Down
ENSG00000104728 ARHGEF10 0.00280 –1.64612 0.04222 Down
ENSG00000134955 SLC37A2 1.42E – 06 –1.64513 0.00018 Down
ENSG00000135205 CCDC146 0.00046 –1.63602 0.01302 Down

3.2. Reconstruction of lncRNA-Associated ceRNA Network

To evaluate whether ceRNA is involved in endothelial cells after stretched, we combined the data acquired in the online database with the data above and constructed a lncRNA-miRNA-mRNA network (Figure 3) based on the ceRNA hypothesis. We identified a total of 13 lncRNAs, 44 miRNAs, and 115 mRNAs as targets in the ceRNA network. In the network, lncRNAs and miRNAs were binding with mRNAs competitively, the cyclic stretch downregulated lncRNAs, thus increased miRNAs and targeted mRNAs indirectly. For example, lncRNA ASCC3 was downregulated, while miR-4728-5p was upregulated, resulting in the decline of Notch2. These data indicated that lncRNA could regulate the expression of mRNA by interacting with miRNA competitively and plays a regulatory role in transcription signals under circumferential stress.

Figure 3.

Figure 3

The lncRNA-miRNA-mRNA competing endogenous RNA network in HUVECs stimulated by cyclic stretch. The rectangles indicate lncRNAs in green, ellipses represent miRNAs in red, and diamonds represent mRNAs in light red.

3.3. GO and KEGG Analysis of Differentially Expressed mRNAs

To annotate functions of the mRNAs in the ceRNA network, we performed GO and KEGG enrichment using David tools and WEB-based gene set analysis. GO analysis indicated that most of the genes were involved in biological regulation, metabolic process, and response to stimulus and located in nucleus and membrane; furthermore, the majority of genes were related to protein binding as molecular function (Figure 4), indicating their pivotal role in transcriptional regulation. Meanwhile, KEGG pathway analysis showed that several pathways were associated with the differentially expressed mRNAs including longevity regulating, cell cycle, mTOR signal, FoxO signal, and MAPK signal (Figure 5), which suggests that they may be involved in proliferation and inflammation in endothelial cells.

Figure 4.

Figure 4

GO enrichment analysis of differentially expressed genes of cyclic stress vein genes (Top 10). (a) Red bar plot of biological process. (b) Blue bar plot of cellular component. (c) Green bar plot of molecular function.

Figure 5.

Figure 5

The top 10 enriched KEGG pathways of cyclic stretch mRNAs in the ceRNA networks.

3.4. Identification of lncRNA NEAT1-Associated Subnetwork

To identify the hub RNAs and their related networks, we calculated the degrees of each node in the ceRNA network using Cytoscape plugin cytoHubba, and the top 20 nodes were ranked by degrees as shown in Table 4. It showed that lncRNA NEAT1 is among the top-ranked nodes, indicating its important role in transcriptional regulation. Therefore, we extracted a subnetwork of lncRNA NEAT1-miRNA-mRNA out of the ceRNA network, which was composed of 1 lncRNA node, 17 miRNA nodes, 13 mRNA nodes, and 67 edges (Figure 6), and it may be the center of the whole ceRNA network. Several RNAs that had been broadly studied such as miR-let7 cluster and MAP4K4 are involved in the subnetwork, suggesting that the subnetwork may regulate biological processes through various pathways.

Table 4.

The list of differentially expressed genes (node degree >5).

Number Gene type Gene symbol Degree
1 miRNA hsa-miR-4739 35
2 lncRNA NEAT1 18
3 miRNA hsa-miR-6756-5p 17
4 miRNA hsa-miR-4685-5p 16
5 miRNA hsa-miR-5787 14
6 miRNA hsa-miR-15a-5p 12
7 miRNA hsa-miR-619-5p 12
8 mRNA MAP3K2 11
9 miRNA hsa-miR-424-5p 11
10 miRNA hsa-miR-15b-5p 11
11 miRNA hsa-miR-497-5p 11
12 miRNA hsa-miR-16-5p 11
13 miRNA hsa-miR-6779-5p 11
14 miRNA hsa-miR-6848-5p 10
15 mRNA RASA1 10
16 miRNA hsa-miR-195-5p 10
17 miRNA hsa-miR-5001-5p 10
18 mRNA MAP4K4 9
19 mRNA PTPRJ 9
20 miRNA hsa-miR-4728-5p 8

Figure 6.

Figure 6

The subnetwork of lncRNA NEAT1 interaction network. The rectangles indicate lncRNAs in green, ellipses represent miRNAs in red, and diamonds represent mRNAs in green.

3.5. Downregulated NEAT1 Validation

In order to validate the expression of NEAT1 in endothelial cells under cyclic stretch, quantitative real-time polymerase chain reaction (qRT-PCR) was performed in the 6 samples above. As shown in Figure 7, lncRNA NEAT1 was significantly downregulated in endothelial cells after being stretched for 24 hours, which was consistent with the RNA-seq data. These results indicated that NEAT1 may play an essential role in the ceRNA network.

Figure 7.

Figure 7

The relative miRNA expression of NEAT1 (normalized to GADPH). NEAT1 level was significantly downregulated in cells of the ST-24 group, in comparison with those of the control group (P < 0.05).

3.6. Secretion of Inflammatory Cytokines

To further investigate the effect on inflammatory response after NEAT1 downregulation, we transduced si-NEAT1 into endothelial cells for 24 h and performed ELISA to measure the level of IL-6, MCP-1, and ICAM-1 in the culture medium. After decreasing NEAT1 for 24 h, IL-6 and MCP-1 were significantly increased by about 1 hold (Figure 8), indicating reducing NEAT1 can worsen endothelial inflammatory and may contribute to vein graft failure.

Figure 8.

Figure 8

The secretion of inflammatory cytokines measured by ELISA. After si-NEAT1 was transduced into endothelial cells for 24 h, inflammatory cytokines including IL-6 and MCP-1 were significantly increased, comparing to the control group (P < 0.05).

3.7. Endothelial Apoptosis Induction

Apart from inflammatory response, we also adopted TUNEL assay to determine the apoptotic effect after downregulating NEAT1. As depicted in Figure 9, fewer TUNEL-positive cells were found in cells treated with si-NEAT1 for 24 h than those with negative control. NEAT1 inhibition leaded to significant endothelial apoptosis, which may result in the aggregation and adhesion of platelet and lead to vein graft failure eventually.

Figure 9.

Figure 9

The endothelial cell apoptosis induced by transduction of si-NEAT1. Endothelial cell apoptosis was increased after NEAT1 silencing, and TUNEL-positive cells appeared less in the si-NEAT1 group.

4. Discussion

Our results indicate that the lncRNA-associated ceRNA network may function as a transcriptional regulation factor in endothelial cells under cyclic stretch, and we further identified that lncRNA NEAT1 may be a target for further investigation of mechanisms in endothelial cells; by triggering inflammatory response and inducing apoptosis, NEAT1 may play an integral role in vein graft failure and could be a target for RNAi therapy.

Vein graft failure, which was characterized as narrow or occlusion of the saphenous vein grafting from the aorta to the coronary artery, limits the long-term effect of CABG. The velocity of the grafted vein reduced to 80% only 1 year after grafting and then to 40% within 10 years [23], resulting in the long-term patency of vein grafts are merely 60%–65% [24] and causing angina recurrence and revascularization [25]. The mechanotransduction of a grafted vein involves the response to shear stress, cyclic stress, and normal stress. Bondareva reported that oscillatory shear stress (OSS) stimulation for 6 hours could activate the EGR1 and YAP/TAZ complex in human endothelial cells, based on ChIP-seq and luciferase assays [26]. Moreover, Moonen et al. suggested that disturb laminar shear stress (LSS) could aggravate endothelial-to-mesenchymal transition (EndMT), targeting MEK5 signaling, eventually leading to neointimal hyperplasia [27]. Similarly, certain progress has been made in the studies on its effect under circumferential stress. For example, high-cyclic stretch significantly elevated miR-124-3p, downregulating lamin A/C and inducing VSMC apoptosis [28]. Cyclic stretch is an initial factor of vein graft failure; after CABG, the stretch rate of the saphenous vein will be 10–15% due to the pulsating pressure from the aorta [29], which causes over deformation of the endothelium. Endothelial cells, located on the inner layer of the saphenous vein, are sensible to the hemodynamic changes; thus, overstretching them will initiate inflammation and proliferation [30]. As a result, cyclic stretch caused by the aorta triggers endothelial dysfunction, which is a key process of vein graft failure [31]. Furthermore, cyclic stretch induces a large number of growth factors releasing from VSMCs, aggregating endothelial dysfunction, and intimal hyperplasia, which eventually results in vein graft failure [32]. Take together, cyclic stretch stimulation to endothelial cells and its inflammation is the early response of vein graft failure. However, the transcriptional regulation in the endothelial dysfunction remains unclear.

Noncoding RNA is a cluster of RNAs that regulate transcription without expressing into protein, mainly including miRNA, lncRNA, and circRNA [33]. miRNAs are single-stranded and endogenously expressed small noncoding RNAs molecules with lengths of 22 to 24 nucleotides [34]. MiRNA plays a regulatory role in numerous cellular activities, including growth, differentiation, metabolism, apoptosis, and migration [35]. Recently, accumulated studies have shown the role of lncRNAs in various biological processes. Aberrantly expressed lncRNA has been observed in coronary artery disease [36]; furthermore, it was found that lncRNA can regulate mRNA expression by interacting with miRNA, leading to the introduction of ceRNA hypothesis [37]. Further studies have shown that ceRNA genes were mediated by miRNAs which are interacting with increasingly complicated ceRNA networks [38]. The ceRNA network has been found to be involved in the pathogenesis in several diseases; however, very little was found on the association between ceRNA and vein graft failure.

To identify the regulatory role of lncRNA-associated ceRNA network in endothelial dysfunction, we constructed a ceRNA network based on RNA-sequencing data of endothelial cells under cyclic stretch for 24 hours. With FC ≥ 1.5 and P value <0.05 threshold, 39 upregulated and 116 downregulated lncRNAs, 35 upregulated and 39 downregulated miRNAs, and 568 upregulated and 392 downregulated mRNAs showed differential expression between two groups. Among them, several genes have been found to be associated with the pathogenesis of vein graft failure. For instance, our previous study found that egr1 was upregulated under cyclic stretch, targeting ICAM-1, leading to vein graft failure [39]. Furthermore, NF-κB is proved to play an integral role in vascular inflammation, and it has been demonstrated that inhibition of NF-κB signaling can reduce the inflammatory response in endothelial cells [40]. On the other hand, activation of the NF-κB pathway is found to impede recovery in the carotid artery injury model [41].

In order to better annotate the biological functions of the downstream mRNAs, we enriched GO and KEGG pathways. Among the most enriched GO terms, biological regulation and response to stimulus have been reported to be involved in endothelial dysfunction. Remarkably enriched KEGG pathways are mTOR, FoxO, and MAPK pathways, and they are known to play an essential role in endothelial dysfunction [4244], causing inflammation and proliferation of the tunica intima.

Our bioinformatic analysis has also determined that the lncRNA nuclear paraspeckle assembly transcript 1 (NEAT1) is the core of the mechanical stress factor. NEAT1 has been reported as a cancer biomarker [45]. In the current study, the total RNA was extracted after stretching for 24 h and we found that NEAT1 expression was significantly decreased, which was consistent with the result of bioinformatics analysis. NEAT1 is a nuclear-enriched lncRNA located on chromosome 11q13.1 and is considered to promote carcinogenesis and metastasis [46]. The upregulation of NEAT1 has been documented in kidney cancer, ovarian cancer, lung cancer, breast cancer, and glioma cancers, contributing to the accurate prediction of clinical outcomes [47, 48]. Recently, NEAT1 is found to be related to the inflammation response to stimuli [49], regulating the expression of several chemokines and cytokines, including IL-6 and CXCL10, via the MAPK pathway [50]. Our present study indicated that NEAT1 expression was downregulated in endothelial cells after mechanical stretch, subsequently leading to upregulated expression of miRNAs and eventually triggering inflammation response to give rise to vein graft failure. NEAT1 is a potent inflammatory regulator; to the best of our knowledge, our study is the first to report its role in ceRNA.

According to the bioinformatic enrichment and PCR validation, we investigated the endothelial inflammation and apoptosis after NEAT1 was repressed by performing ELISA and TUNEL assays. Similar to the results of previous studies, after transduction of si-NEAT1 for 24 h, inflammatory cytokines were significantly increased in the culture medium. Due to the structural difference between the vein and artery, the endothelial layer of the saphenous vein is prone to cyclic stretch, and the high pressure of the aorta after grafting leads to EC activation and loss, initiating the complex networks and leading to rapid expression of a cascade of adhesion such as MCP-1 and ICAM-1 [51]. Apart from that, endothelial cells are essential parts of vascular homeostasis to maintain a anticoagulant and anti-inflammation environment [52]. TUNEL staining showed that inhibiting NEAT1 can induce endothelial cells apoptosis, which may lead to the exposure of smooth muscle cells, leading to phenotype switch, aggregating intimal hyperplasia, and resulting vein graft failure [53].

Nevertheless, more studies should be carried out to clarify the role of NEAT1 during vein graft failure. Different cyclic stress times and frequencies should be further investigated in future studies in the ceRNA network. In addition, further studies should be made on validation of the downstream genes; moreover, the various reasons to explain the failure of vein graft should be elucidated.

In conclusion, we constructed a lncRNA-associated ceRNA network based on the sequencing data and identified lncRNA NEAT1 is an essential fraction in endothelial dysfunction. We found that cyclic stress in the endothelial cells gives rise to inflammatory response and promotes cell apoptosis by downregulating NEAT1 and its related ncRNAs. Our study provided a novel insight into the transcriptional regulation of vein graft failure.

Acknowledgments

The authors thank Dr. Xueting Huang for her kind and patient assistance. This work was supported by the National Natural Science Foundation of China (grant nos. 81570373 and 81770412).

Contributor Information

Jubing Zheng, Email: zhengjubing@hotmail.com.

Ran Dong, Email: dongran6618@hotmail.com.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that there are no conflicts of interest.

References

  • 1.Cohen D. J., Osnabrugge R. L., Magnuson E. A., et al. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial. Circulation. 2014;130(14):1146–1157. doi: 10.1161/circulationaha.114.009985. [DOI] [PubMed] [Google Scholar]
  • 2.Goldman S., Zadina K., Moritz T., et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a department of veterans affairs cooperative study. Journal of the American College of Cardiology. 2004;44(11):2149–2156. doi: 10.1016/j.jacc.2004.08.064. [DOI] [PubMed] [Google Scholar]
  • 3.Shukla N., Jeremy J. Y. Pathophysiology of saphenous vein graft failure: a brief overview of interventions. Current Opinion in Pharmacology. 2012;12(2):114–120. doi: 10.1016/j.coph.2012.01.001. [DOI] [PubMed] [Google Scholar]
  • 4.Jeremy J. Y., Mehta D., Bryan A. J., Lewis D., Angelini G. D. Platelets and saphenous vein graft failure following coronary artery bypass surgery. Platelets. 1997;8(5):295–309. doi: 10.1080/09537109777168. [DOI] [PubMed] [Google Scholar]
  • 5.Newby A. C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiological Reviews. 2005;85(1):1–31. doi: 10.1152/physrev.00048.2003. [DOI] [PubMed] [Google Scholar]
  • 6.Kenagy R. D., Fukai N., Min S.-K., Jalikis F., Kohler T. R., Clowes A. W. Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis. Journal of Vascular Surgery. 2009;49(5):1282–1288. doi: 10.1016/j.jvs.2008.12.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Spadaccio C., Antoniades C., Nenna A., et al. Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure and internal thoracic arteries? Cardiovascular Research. 2019 doi: 10.1093/cvr/cvz214. [DOI] [PubMed] [Google Scholar]
  • 8.Wadey K., Lopes J., Bendeck M., George S. Role of smooth muscle cells in coronary artery bypass grafting failure. Cardiovascular Research. 2018;114(4):601–610. doi: 10.1093/cvr/cvy021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.McDonald R. A., Halliday C. A., Miller A. M., et al. Reducing in-stent restenosis: therapeutic manipulation of miRNA in vascular remodeling and inflammation. Journal of the American College of Cardiology. 2015;65(21):2314–2327. doi: 10.1016/j.jacc.2015.03.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.McDonald R. A., White K. M., Wu J., et al. miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation. European Heart Journal. 2013;34(22):1636–1643. doi: 10.1093/eurheartj/eht105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Cheng Y., Liu X., Yang J., et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circulation Research. 2009;105(2):158–166. doi: 10.1161/circresaha.109.197517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ohnaka M., Marui A., Yamahara K., et al. Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype. The Journal of Thoracic and Cardiovascular Surgery. 2014;148(2):676–682.e2. doi: 10.1016/j.jtcvs.2013.11.054. [DOI] [PubMed] [Google Scholar]
  • 13.Meloni M., Marchetti M., Garner K., et al. Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction. Molecular Therapy. 2013;21(7):1390–1402. doi: 10.1038/mt.2013.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Daniel J.-M., Penzkofer D., Teske R., et al. Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury. Cardiovascular Research. 2014;103(4):564–572. doi: 10.1093/cvr/cvu162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kong L., Zhang Y., Ye Z.-Q., et al. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Research. 2007;35(2):W345–W349. doi: 10.1093/nar/gkm391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kozomara A., Birgaoanu M., Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Research. 2019;47(D1):D155–d162. doi: 10.1093/nar/gky1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Li R., Qu H., Wang S., et al. GDCRNATools: an R/bioconductor package for integrative analysis of lncRNA, miRNA and mRNA data in GDC. Bioinformatics. 2018;34(14):2515–2517. doi: 10.1093/bioinformatics/bty124. [DOI] [PubMed] [Google Scholar]
  • 18.Li J.-H., Liu S., Zhou H., Qu L.-H., Yang J.-H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Research. 2014;42(D1):D92–D97. doi: 10.1093/nar/gkt1248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Jeggari A., Marks D. S., Larsson E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics. 2012;28(15):2062–2063. doi: 10.1093/bioinformatics/bts344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chou C.-H., Shrestha S., Yang C.-D., et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Research. 2018;46(D1):D296–d302. doi: 10.1093/nar/gkx1067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Huang D. W., Sherman B. T., Zheng X., et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research. 2009;37(1):1–13. doi: 10.1093/nar/gkn923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Liao Y., Wang J., Jaehnig E. J., Shi Z., Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Research. 2019;47(W1):W199–w205. doi: 10.1093/nar/gkz401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.von Bornstädt D., Wang H., Paulsen M. J., et al. Rapid self-assembly of bioengineered cardiovascular bypass grafts from scaffold-stabilized, tubular bilevel cell sheets. Circulation. 2018;138(19):2130–2144. doi: 10.1161/circulationaha.118.035231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hess C. N., Lopes R. D., Gibson C. M., et al. Saphenous vein graft failure after coronary artery bypass surgery: insights from prevent IV. Circulation. 2014;130(17):1445–1451. doi: 10.1161/circulationaha.113.008193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Neumann F. J., Sousa-Uva M., Ahlsson A., et al. 2018 ESC/EACTS guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):79–80. doi: 10.1093/eurheartj/ehy855. [DOI] [PubMed] [Google Scholar]
  • 26.Li B., He J., Lv H., et al. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow. Journal of Clinical Investigation. 2019;129(3):1167–1179. doi: 10.1172/jci122440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Moonen J.-R. A. J., Lee E. S., Schmidt M., et al. Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress. Cardiovascular Research. 2015;108(3):377–386. doi: 10.1093/cvr/cvv175. [DOI] [PubMed] [Google Scholar]
  • 28.Bao H., Li H. P., Shi Q., et al. Lamin A/C negatively regulated by miR-124-3p modulates apoptosis of vascular smooth muscle cells during cyclic stretch application in rats. Acta Physiologica. 2019 doi: 10.1111/apha.13374.e13374 [DOI] [PubMed] [Google Scholar]
  • 29.Bondareva O., Tsaryk R., Bojovic V., Odenthal-Schnittler M., Siekmann A. F., Schnittler H.-J. Identification of atheroprone shear stress responsive regulatory elements in endothelial cells. Cardiovascular Research. 2019;115(10):1487–1499. doi: 10.1093/cvr/cvz027. [DOI] [PubMed] [Google Scholar]
  • 30.Lemarié C. A., Tharaux P.-L., Lehoux S. Extracellular matrix alterations in hypertensive vascular remodeling. Journal of Molecular and Cellular Cardiology. 2010;48(3):433–439. doi: 10.1016/j.yjmcc.2009.09.018. [DOI] [PubMed] [Google Scholar]
  • 31.Stigler R., Steger C., Schachner T., et al. The impact of distension pressure on acute endothelial cell loss and neointimal proliferation in saphenous vein grafts. European Journal of Cardio-Thoracic Surgery. 2012;42(4):e74–e79. doi: 10.1093/ejcts/ezs402. [DOI] [PubMed] [Google Scholar]
  • 32.Peppel K., Zhang L., Orman E., et al. Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms. Cardiovascular Research. 2005;65(3):674–682. doi: 10.1016/j.cardiores.2004.10.031. [DOI] [PubMed] [Google Scholar]
  • 33.Taft R. J., Pang K. C., Mercer T. R., Dinger M., Mattick J. S. Non-coding RNAs: regulators of disease. The Journal of Pathology. 2010;220(2):126–139. doi: 10.1002/path.2638. [DOI] [PubMed] [Google Scholar]
  • 34.Pasquinelli A. E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nature Reviews Genetics. 2012;13(4):271–282. doi: 10.1038/nrg3162. [DOI] [PubMed] [Google Scholar]
  • 35.Zhou S.-s., Jin J.-p., Wang J.-q., et al. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacologica Sinica. 2018;39(7):1073–1084. doi: 10.1038/aps.2018.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wang H., Zhang N., Li G., Xu B. Proinflammatory cytokine IFN-γ, lncRNA BANCR and the occurrence of coronary artery disease. Life Sciences. 2019;231:p. 116510. doi: 10.1016/j.lfs.2019.05.066. [DOI] [PubMed] [Google Scholar]
  • 37.Salmena L., Poliseno L., Tay Y., Kats L., Pandolfi P. P. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–358. doi: 10.1016/j.cell.2011.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Tay Y., Rinn J., Pandolfi P. P. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352. doi: 10.1038/nature12986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Zhang K., Cao J., Dong R., Du J. Early growth response protein 1 promotes restenosis by upregulating intercellular adhesion molecule-1 in vein graft. Oxidative Medicine and Cellular Longevity. 2013;2013:9. doi: 10.1155/2013/432409.432409 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Song W., Yang Z., He B. Bestrophin 3 ameliorates TNFalpha-induced inflammation by inhibiting NF-kappaB activation in endothelial cells. PLoS One. 2014;9(10) doi: 10.1371/journal.pone.0111093.e111093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Han S., Xu S., Zhou J., et al. Sam68 impedes the recovery of arterial injury by augmenting inflammatory response. Journal of Molecular and Cellular Cardiology. 2019;137:82–92. doi: 10.1016/j.yjmcc.2019.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Korybalska K., Kawka E., Breborowicz A., Witowski J. The role of mTOR inhibitors and HMG-CoA reductase inhibitors on young and old endothelial cell functions, critical for re-endothelialisation after percutaneous coronary intervention: an in vitro study. Journal of Physiology and Pharmacology. 2017;68(3):397–405. [PubMed] [Google Scholar]
  • 43.Wilhelm K., Happel K., Eelen G., et al. FOXO1 couples metabolic activity and growth state in the vascular endothelium. Nature. 2016;529(7585):216–220. doi: 10.1038/nature16498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Yang L., Bai Y., Li N., et al. Vascular VPO1 expression is related to the endothelial dysfunction in spontaneously hypertensive rats. Biochemical and Biophysical Research Communications. 2013;439(4):511–516. doi: 10.1016/j.bbrc.2013.09.012. [DOI] [PubMed] [Google Scholar]
  • 45.Klec C., Prinz F., Pichler M. Involvement of the long noncoding RNA NEAT1 in carcinogenesis. Molecular Oncology. 2019;13(1):46–60. doi: 10.1002/1878-0261.12404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kong X., Zhao Y., Li X., Tao Z., Hou M., Ma H. Overexpression of HIF-2alpha-Dependent NEAT1 promotes the progression of non-small cell lung cancer through miR-101-3p/SOX9/Wnt/beta-Catenin signal pathway. Cellular Physiology and Biochemistry. 2019;52(3):368–381. doi: 10.33594/000000026. [DOI] [PubMed] [Google Scholar]
  • 47.Wu Y., Wang H. LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway. Journal of Biochemical and Molecular Toxicology. 2018;32(1) doi: 10.1002/jbt.22008. [DOI] [PubMed] [Google Scholar]
  • 48.Zhang X.-N., Zhou J., Lu X.-J. The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3. Journal of Cellular Physiology. 2018;233(9):6733–6741. doi: 10.1002/jcp.26371. [DOI] [PubMed] [Google Scholar]
  • 49.Zhang P., Cao L., Zhou R., Yang X., Wu M. The lncRNA Neat1 promotes activation of inflammasomes in macrophages. Nature Communications. 2019;10(1):p. 1495. doi: 10.1038/s41467-019-09482-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Zhang F., Wu L., Qian J., et al. Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. Journal of Autoimmunity. 2016;75:96–104. doi: 10.1016/j.jaut.2016.07.012. [DOI] [PubMed] [Google Scholar]
  • 51.Ward A. O., Caputo M., Angelini G. D., George S. J., Zakkar M. Activation and inflammation of the venous endothelium in vein graft disease. Atherosclerosis. 2017;265:266–274. doi: 10.1016/j.atherosclerosis.2017.08.023. [DOI] [PubMed] [Google Scholar]
  • 52.Chiu J.-J., Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiological Reviews. 2011;91(1):327–387. doi: 10.1152/physrev.00047.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Hu Y., Mayr M., Metzler B., Erdel M., Davison F., Xu Q. Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circulation Research. 2002;91(7):e13–20. doi: 10.1161/01.res.0000037090.34760.ee. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data used to support the findings of this study are available from the corresponding author upon request.


Articles from Cardiology Research and Practice are provided here courtesy of Wiley

RESOURCES